{
  "insp_id": "2016090000778726",
  "layout": "b",
  "customer_id": "334624",
  "customer_name": "ANGIOGRAFT LLC",
  "customer_addr": "BAIRD RESEARCH PARK\n1576 SWEET HOME RD SUITE 209\nAMHERST, NY 14228",
  "certificate": "21-R-0243",
  "site_id": "002",
  "site_name": "ANGIOGRAFT LLC",
  "insp_type": "ROUTINE INSPECTION",
  "date": "30-MAR-2022",
  "report_date": "01-APR-2022",
  "citations": [
    {
      "code": "2.31(d)(1)(iv)(A)",
      "kind": "",
      "repeat": false,
      "desc": "Institutional Animal Care and Use Committee (IACUC).",
      "narrative": "A review of sheep surgical records revealed the euthanasia method as a compound which is not available in a\npharmaceutical formulation. There is no justification for using a non-pharmaceutical grade compound for euthanasia in the\nIACUC approved protocol. The use of non-pharmaceutical grade substances for euthanasia must be documented and\njustified and approved by the IACUC. The facility must correct this issue.\n*******Correct by May 15, 2022"
    },
    {
      "code": "2.32(a)",
      "kind": "",
      "repeat": false,
      "desc": "Personnel qualifications.",
      "narrative": "In reviewing the approved protocol 10-18 it was determined that the study staff made a significant change regarding the\neuthanasia method used after the surgical/study procedures without the IACUC first reviewing and approving the change.\nThis change was made by the investigator without notifying the IACUC and allowing them to review the modifications.\nTo ensure the well-being and humane treatment of all research animals, it is important for the IACUC to review and\napprove any significant changes regarding the care and use of animals in ongoing research activities. Correct by allowing\nthe IACUC to review and either approve, require modifications in, or withhold approval of proposed significant changes\nregarding the care and use of animals in ongoing activities.\n******Correct by May 29, 2022\nThis inspection and exit interview were conducted with the facility representative.\nEnd Section"
    }
  ],
  "narrative": "2.31(d)(1)(iv)(A) \n   \nInstitutional Animal Care and Use Committee (IACUC). \nA review of sheep surgical records revealed the euthanasia method as a compound which is not available in a \npharmaceutical formulation. There is no justification for using a non-pharmaceutical grade compound for euthanasia in the \nIACUC approved protocol. The use of non-pharmaceutical grade substances for euthanasia must be documented and \njustified and approved by the IACUC. The facility must correct this issue. \n*******Correct by May 15, 2022 \n2.32(a) \n   \nPersonnel qualifications. \nIn reviewing the approved protocol 10-18 it was determined that the study staff made a significant change regarding the \neuthanasia method used after the surgical/study procedures without the IACUC first reviewing and approving the change. \nThis change was made by the investigator without notifying the IACUC and allowing them to review the modifications. \n \nTo ensure the well-being and humane treatment of all research animals, it is important for the IACUC to review and \napprove any significant changes regarding the care and use of animals in ongoing research activities. Correct by allowing \nthe IACUC to review and either approve, require modifications in, or withhold approval of proposed significant changes\n\nregarding the care and use of animals in ongoing activities. \n******Correct by May 29, 2022 \n \nThis inspection and exit interview were conducted with the facility representative. \n \nEnd Section",
  "animals_total": 0,
  "species": [
    {
      "count": 0,
      "scientific": "NONE",
      "common": "NONE"
    }
  ]
}